Episode Details

The EU rushed the purchase of more than €35 billion Pfizer-BioNTech mRNA vaccines in 2020–2021, the largest in history. If you think that’s a lot of money, you’re mistaken. With strong-willed Europeans going to bat for their people, there’s going to be hell to pay.

German Member of Parliament, Christine Anderson, recently stood before the world in Brussels and shook the European Parliament. Ursula von der Leyen contributed €35 billion to Pfizer mRNA contracts and she wants to know why. She also tried to hide her contribution.

Von der Leyen personally negotiated with Bourla, bypassing standard, lawful procedures.

Did she know all along what she was really doing with that big of a chunk of change?

Ursula Gertrud von der Leyen is a German politician, physician, and the first woman to serve as President of the European Commission since July 2019. She was re-elected to a second term in 2024, overseeing the EU’s executive branch, which enforces laws, manages budgets, and drives policies on trade, climate, and health for 450 million citizens across 27 member states.

Her background is in medicine and economics. She’s seemingly blending the World Health Organization (WHO) and World Economic Forum (WEF) models of using people for financial gain while slowly killing them. It’s been lucrative for them thus far.

For direct profits from the “pandemic” alone, not including additional windfalls that would be made due to cancer drugs, Alzheimer’s drugs, drugs for heart disease, etc.

Companies like Pfizer, BioNTech, Moderna, AstraZeneca, Johnson & Johnson, and others all had global sales peaks in 2021–2022 before boosters started to decline because word got out that their shots were killing people: A rough, if not modest, estimate is that they made between $180 and $200 billion.

A likely more accurate estimate is that they made at least $430 to $540 billion generated from COVID-19 vaccines and pandemic-related fallout, like delayed cancer screenings and boosting chronic disease treatments after pushing boosters on all of us.

To give you an idea of just how much money that is, it’s equivalent to a mid-sized country’s annual GDP – like the entire economy in Sweden, Belgium, or Thailand.

Year

Key Revenue Breakdown (USD Billion)

Total

2020

Development phase – about $1B with early trials/distribution

~$1B

2021

Pfizer/BioNTech: $37B (Comirnaty); Moderna: $18B; AstraZeneca: $2B; Others (J&J/Sinovac): $3B

~$60B

2022

Pfizer/BioNTech: $57B (incl. Paxlovid antiviral); Moderna: $19B; AstraZeneca: $3B; Others: $4B

~$83B

2023

Pfizer/BioNTech: $20B; Moderna: $7B; AstraZeneca: $1B; Others: $2B

~$30B

2024

Pfizer/BioNTech: $6B; Moderna: $1B; Others: $1B

~$8B

Anderson accused von der Leyen of deleting text messages with Pfizer’s CEO, Albert Bourla. She’s gathered enough signatures to force an investigation twice, and nothing has come of it. Anderson should have been able to see why von der Leyen was lining Pfizer’s pockets for a bioweapon after 180 MEPs asked for the same information along with her, but the Parliament’s Conference of Presidents met in secret sessions and blocked her and the other MEPs

Anderson says with passion while addressing her peers from Brussels:

“. . .As you know, in the election campaign for EU Parliament, I ran on the promise that I would deliver an inquiry committee into the unspeakable events around mRNA procurement contracts and how Ursula von der